|
Report Date : |
09.06.2012 |
IDENTIFICATION DETAILS
|
Name : |
HANGZHOU SINOLITE INDUSTRIAL CO., LTD |
|
|
|
|
Registered Office : |
Tower J, 23FL, |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
19.07.2006 |
|
|
|
|
Com. Reg. No.: |
330104000002849 |
|
|
|
|
Legal Form : |
Limited Liabilities
Company |
|
|
|
|
Line of Business : |
Wholesale of Pharmaceutical Intermediates |
|
|
|
|
No. of Employees : |
20 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
China |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
HANGZHOU SINOLITE INDUSTRIAL CO., LTD |
|
|
Tower J, 23FL, Zhejiang Material Industrial Building,
No.445, Kaiyuan Rd, Hangzhou City, Zhejiang Province |
|
|
310020 |
|
|
Tel : |
86 571 86772648 |
|
Fax: |
86 571 86772650 |
|
Website: |
http://www.sinolite.net/cn/ |
Currency in this report is Chinese Yuan
unless otherwise stated.
Exchange Rate: 1 USD=6.33 Chinese Yuan
"--"in this report indicates
"unavailable" due to insufficient information or "no
comments"
Note:
Due
to the recent intervention of government in the AIC systems, reports of
companies in some regions could be impacted for a certain period, and for the
companies registered in Zhejiang Province, only the basic registry
information is available. Shareholder and financial information couldn’t be
obtained.
|
DATE OF establishment |
Jul.19th, 2006 |
|
Aic Registration No. |
330104000002849 |
|
REGISTERED LEGAL FORM |
limited liabilities
company |
|
main BUSINESS |
wholesale of pharmaceutical intermediates |
|
SIC Code (China) |
6351 wholesale of western medicine |
|
|
|
|
employees |
20 |
|
import and export permits |
yes |
|
business scale |
Medium |
|
operation trend |
Average |
|
|
|
|
base Credie limit |
N/A |
|
EXCHANGE RATE |
1 Usd=6.33CNY (MAY 21st, 2012) |
|
Name |
HANGZHOU SINOLITE INDUSTRIAL CO., LTD |
|
AIC Registration Number |
330104000002849 |
|
Registered address |
Tower J, 23FL, Zhejiang Material Industrial
Building, No.445, Kaiyuan Rd, Hangzhou City, Zhejiang Province |
|
Operation address |
Tower J, 23FL, Zhejiang Material Industrial
Building, No.445, Kaiyuan Rd, Hangzhou City, Zhejiang Province |
|
Date of Establishment |
Jul.19th, 2006 |
|
Registry |
Administration Bureau for Industry and Commerce – Jianggan Brach,
Hangzhou |
|
Registered Legal Form |
limited liabilities company |
Limited liabilities co.
This form of business in PR China is defined as a
legal person. Its registered capital is contributed jointly by at least two shareholders
and no more than fifty. Shareholders bear limited liability to the extent of
shareholding, and the co. is liable for its debts only to extent of its total
assets. The characteristics of this form of co. are as follows:
Upon the establishment of the co., an investment
certificate is issued to the each of shareholders.
The board of directors is comprised of three to
thirteen members.
The minimum registered capital for a co. is listed
as follows:
-manufacturing co. :
RMB 500,000.00
-trading &wholesaling co. :
RMB 500,000.00
-retailing co. : RMB 300,000.00
-consultancy & service co. :
RMB 100,000.00
Shareholders may take their capital contributions
in cash or by means of tangible assets or intangible assets such as industrial
property and non-patented technology.
Cash contributed by all shareholders must account
for at least 50% of the registered capital while contribution by intangible
assets must not exceed 20% of the registered capital.
Existing shareholders have pre-exemption right to
purchase shares of the co. offered for sale by the other shareholders and to
subscribe for the newly increased registered capital of the co.
N/A
No
affiliate of subject is found after checking.
SC’s
bank information can’t be obtained after searching through all available
channels.
|
Geographic Location |
Tower J, 23FL, Zhejiang Material Industrial
Building, No.445, Kaiyuan Rd, Hangzhou City, Zhejiang Province |
|
Area |
200 square meters |
|
Environment and traffic |
Acceptable |
|
Property Ownership |
Rented |
After checking with the
Trademark Office of Chinese Administration Bureau of Industry and Commerce and
the State Intellectual Office, no trademarks or patents of SC were found.
|
Main business |
Wholesale of pharmaceutical intermediates |
|
Products and services |
Subject’s products include Triethylamine
hydrobromide, Triethylamine hydrobromide, Protected Meropenem etc. |
|
Local sales |
5% |
|
Regions |
Hangzhou
and the surrounding cities |
|
Major domestic clients |
Traders |
|
Payment terms |
Prompt payment; on credit |
|
Export |
95% |
|
Regions |
UAS,
Asia, Europe, Mid-east etc. |
|
Major overseas clients |
International
wholesalers |
|
Payment terms |
L/C, T/T |
|
Subject’s products are
mostly imported. Its clients include international traders, pharmaceutical
manufacturers, chemical manufacturers etc. |
|
|
The above information was
confirmed by SC’s employee on MAY.18th, 2012. |
|
|
Main Commodities Purchased |
Triethylamine hydrobromide, pharmaceutical
intermediates etc. |
|
Region |
Local: 100% Import: 0% |
|
Number of Major Suppliers |
More than 5 |
|
Major suppliers |
CHONGQING FUAN PHARMACEUTICAL (GROUP) CO.,LTD. |
|
Main Terms of Payment |
Local: Prompt payment; on
credit |
|
Subject’s purchase is all done domestically.
Its purchasing region is not fixed. |
|
|
The above information was confirmed by SC’s
employee on MAY.18th, 2012. |
|
|
Name of supplier |
CHONGQING FUAN
PHARMACEUTICAL (GROUP) CO.,LTD |
|
Main commodities and service supplied |
pharmaceutical intermediates |
|
Title of interviewee |
Sales staff |
|
Telephone of Interviewee |
86-23-61028789 |
|
Cooperation |
Confirmed |
|
Payment comment |
Unknown |
After checking with China Court organization,
the local court website and other major searching websites, no litigation record
related to subject company in the latest three years is found.
N/A
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.36 |
|
|
1 |
Rs.85.64 |
|
Euro |
1 |
Rs.69.21 |
INFORMATION DETAILS
|
Report Prepared
by : |
SDA |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.